The latest market report published by Credence Research, Inc. “ In-Vitro Diagnostics Quality Control Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global in-vitro diagnostics quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026.

Market Insights

The global in-vitro diagnostics quality control market is projected to grow at a steady rate during the forecast period . The major reason for the growth of the market includes growing applications of in-vitro diagnostics and point-of-care diagnostics for various diseases such as chronic diseases, infectious diseases and oncology testing. Quick testing and accurate results have positioned in-vitro diagnostics testing in modern healthcare. In-vitro diagnostics fall under medical devices category and hence Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA) and other regulatory bodies have implemented stringent regulatory process for maintaining the standard quality and safety of the testing systems. This factor is the major growth driver for in-vitro diagnostics quality control market. Increasing number of clinical and diagnostics laboratories worldwide is also influencing the market growth. In terms of application, the market is led by clinical chemistry owing to growing application in chronic diseases, most prominently in cancer treatment and cardiovascular treatment. Immunochemistry also held a prominent share in the market due to urgent requirement for novel drug discovery and increasing physician awareness regarding disease etiology will propel market penetration for immunochemistry segment.

Don’t Miss the Sample @ https://www.credenceresearch.com/sample-request/59637